点击显示 收起
| 036 | Gerard Y, Hober D, Petitjean S, Assicot M, Bohuon C, Mouton Q, Wattré P. High serum procalcitonin level in a 4-year-old liver transplant recipient with a disseminated candidiasis Infection 1995; 23: 310-1 |
| 089 | Staehler M, überfuhr P, Reichart B, Hammer C Differentialdiagnostik der Absto?ungsreaktion und Infektion bei herztransplantierten Patienten: neue Wege mit Zytokinen und Procalcitonin als Marker. [Differential diagnosis of acute rejection and infections in heart transplanted patients: new ways using cytokines and procalcitonin as markers] Transplantationsmedizin 1997; 9: 44-50 |
| 090 | Staehler M, Hammer C, Meiser B, Fürst H, Reichhart B, Schildberg FW. Differentialdiagnostik der akuten Absto?reaktion und Infektion mittels Procalcitonin und Zytokinen Langenbecks Arch Chir I (Forumband 1997) 1997; 205-209 |
| 093 | Staehler M, Hammer C, Meiser B, Reichart B. Procalcitonin: A new marker of differential diagnosis of acute rejection and bacterial infection in heart transplantation Transplantation Proceedings 1997; 29: 584-5 |
| 108 | Meisner M, Tschaikowsky K, Schmidt J, Schüttler J Procalcitonin (PCT) - Indications for a new diagnostic parameter of severe bacterial infection and sepsis in transplantation, immunosuppression and cardiac assist devices Cardiovascular Engineering 1996; 1 (1): 67-76 |
| 235 | Eberhard OK, Langefeld I, Kuse ER, Brunkhorst FM, Kliem V, Schlitt HJ, Pichlmayr R, Koch KM, Brunkhorst R. Procalcitonin in the early phase after renal transplantation - will it add to diagnostic accuracy? Clin. Transplantation 1998, 12: 206-211 |
| 237 | Hammer C, Reichenspurner R, Meiser B, Reichart B. Cytoimmunology in monitoring: the Munich experience Transplant. Proceed. 1998, 30: 873-874 |
| 238 | Kunz D, Pross M, K?nig W, Lippert H, Manger T. Diagnostic relevance of procalcitonin, IL-6 and cellular immune status in the early phase after liver transplantation Transplant. Proceed. 1998, 30: 2398-2399 |
| 256 | Pross M, Manger Th, Weiss G, Lippers H, K?nig W, Kunz D. The diagnostic value of procalcitonin and IL-6 in combination with the cellular immune status for the therapeutic management after liver transplantation (in German) Tx Med 1998, 10: 195-201 |
| 269 | Hammer S, Meisner F, Dirschedl P, H?bel G, Fraunberger P, Meiser B, Reichardt b, Hammer C. Procalcitonin: a new marker for diagnosis of acute rejection and bacterial infection in patients after heart and lung transplantation Transplant Immunology 1998, 6: 235-241 |
| 341 | Jaresová M, Striz I, Cermaková, Lácha J, Sedlácek J, Mudra K, Hána I, Vitko S. Serum procalcitonin in transplant patients with acute rejection and bacterial infections Immunology Letters 1999, 69: 355-358 |
| 352 | Kuse ER, Langefeld I, Jaeger K, Külpmann WR Procalcitonin in fever of unknown origin after liver transplantation: A variable to differentiate acute rejection from infection Crit. Care Med. 2000, 28(2): 555-559 |
| 353 | Hammer S, Fraunberger P, Meiser B, Stangl M, Seidel D, Hammer C. Procalcitonin, a new indicator for non-viral infections in heart, lung or liver transplant patients Ann. Tranplant. 1999, 4(2): 5-9 |
| 354 | Hammer S, Meisner F, Hammer C, Seidel D. Use of procalcitonin as indicator of nonviral infections in transplantation and related immunologic diseases Tranplant. Reviews 2000, 14(1): 52-63 |
| 368 | Hammer S, Meisner F, Dirschedl P, Fraunberger P, Meiser B, Reichart B, Hammer C Procalcitonin for differential diagnosis of graft rejection and infection in patients with heart and/or lung grafts Intensive Care Med. 2000, 26(Suppl 2): S182-186 |
| 369 | Kuse ER, Langefeld I, Jaeger K, Külpmann WR Procalcitonin - a new diagnsotic tool in complications following liver transplantation Intensive Care Med. 2000, 26(Suppl 2): S187-192 |
| 375 | Hammer S, Meisnera F, Beiras-Fernandez, Meiser B, Fraunberger P, Hammer C Procalcitonin: a new marker for the diagnosis of organ rejection and bacterial infections in patients receiving heart and lung transplants [in Spanish] Transplantes 1999, 5:26-32 |
| 439 | Boeken U, Feindt P, Micek M, schulte HD, Gams E. Procalcitonin (PCT) in cardiac surgery: diagnostic value in systemic inflammatory response syndrome (SIRS), sepsis and after heart transplantation (HTX) Cardiovasc. Surg. 2000, 8(7): 550-554 |
| 455 | Kornberg A, Grunbe T, Wagner T, Voigt R, Homman M, Schotte U, Schmidt K, Scheele J. Differentiated therapy with prostaglandin E1 (Alprostadil) after orthotopic liver transplantation: the usefulness of procalcitonin (PCT) and hepatic artery resistive index (RI) for the evaluation of early graft function and clinical course. Clin Chem Lab Med 2000, 38(11): 1177-1180 |
| 475 | Kuse ER and Jaeger K. Procalcitonin increases after anti-CD3 monoclonal antibody therapy does not indicate infectious disease Transpl Int 2001, 14: 55 |
| 476 | Wagner FD, Jonitz B, Qedra N, Wegscheider K, Weinmann E, Loebe M, Hetzer R. Procalcitonin: A donor-specific predictor of early graft failure and early graft failure mortality after heart transplantation J Heart Lung Transplant 2001, 20(2): 206 |
| 477 | Qedra N, Wagner F, Jonitz B, Loebe M, Abraham K, Hetzer R. Procalcitonin (PCT) is a new biological marker for the diagnosis of non-viral infections after transplantation of intrathoracic organs J Heart Lung Transplant 2001, 20(2): 239 |
| 479 | Cooper D, Sharples L, Cornelissen J, Wallwork J, Alexander G, Trull A. Comparison betweem procalcitonin, serum amyloid A, and C-reactive protein as markers of serious bacterial and fungal infections after solid organ transplantation Transplant Proc 2001, 33(1-2): 1808-1810 |
| 490 | Sabat R, H?flich C, D?cke W-D, Oppert M, Kern F, Windrich B, Rosenberger C, Kaden J, Volk H-D, Reinke P. Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies Int Care Med 2001, 27: 987-991 |
| 500 | Hammer C, Fraunberger P, Meiser B, Hammer S. Procalcitonin: A new marker of diagnosis of acute rejection and nonviral infection of heart and lung transplant patients Transplant Proceed. 2001, 33:2204-2206 |
| 541 | Stríz L, Jaresova M, Lácha J, Sedlácek J, Vitko S. MRP 8/14 and procalcitonin serum levels in organ transplantations Ann Tranplant 2001, 6(2): 6-9 |
| 547 | Hammer C., H?bel G., Hammer S., Fraunberger P., Meiser B. Diagnosis and monitoring of inflammatory events in transplant patients Biomarkers of Disease. An Evidence-Based Approach, Trull AK et al (ed) Cambridge University Press 2002, pages 474-481 |